Study of Postoperative 3D-CRT/IMRT in Hepatocellular Carcinoma
Status
Conditions
Treatments
Details and patient eligibility
About
Hepatectomy is difficult when the tumor is adjacent to the big vessels of the liver and some patients can not receive radical resection. Such patients have high risk of recurrence. Tumor resection and postoperative radiation is an option for such patients to achieve radical treatment and radiation may reduce local recurrence.
Full description
Patients with risk factors of recurrence receive postoperative radiotherapy using intensive modulated radiation therapy (IMRT) or three-dimensional conformal radiation therapy (3DCRT). The clinical target volume includes tumor bed. The dose will be 50-60Gy/25-30f. Overall survival, local-recurrence free survival, disease free survival and toxicity need be observed.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- written informed consent provided
- 18~75 years old
- patients with histopathological proved hepatocellular carcinoma received hepatectomy and had at least one risk factor of recurrence
- without any lymph node or distant metastasis (any T N0M0)
- liver function: Child-Pugh A or B
- Performance status: Karnofsky (KPS)≥70 or world health organization(WHO) score 0,1
- life expectation>6 months
- no dysfunction of major organs
- no prior radiotherapy
- negative for human immunodeficiency virus syndrome (HIV)
- Considerable to computed tomography(CT) simulation and 3D-CRT or IMRT
Exclusion criteria
- malignant tumors of other sits
- combining severe diseases, such as acute myocardial infarction(AMI), arrhythmias, infection
- surgery performed in other hospitals without details
- pregnant woman or woman need to breast feed or woman with positive chorionic gonadotrophin (HCG)
Trial design
Primary purpose
Allocation
Interventional model
Masking
76 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal